相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
Cecylia S. Lupala et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Emerging mutation patterns in SARS-CoV-2 variants
David A. Ostrov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
Yusha Araf et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Proteolytic activation of SARS-CoV-2 spike protein
Makoto Takeda
MICROBIOLOGY AND IMMUNOLOGY (2022)
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy G. Thorne et al.
NATURE (2022)
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
Increased transmissibility of the alpha SARS-CoV-2 variant: evidence from contact tracing data in Oslo, January to February 2021
Jonas Christoffer Lindstrom et al.
INFECTIOUS DISEASES (2022)
IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
Massimo Palatini et al.
VIRUSES-BASEL (2022)
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Yang Liu et al.
CELL REPORTS (2022)
Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein
Mizuki Yamamoto et al.
MBIO (2022)
Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters
Bobo Wing-Yee Mok et al.
COMMUNICATIONS BIOLOGY (2021)
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation
Maaran Michael Rajah et al.
EMBO JOURNAL (2021)
A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein
Sylvie Roy et al.
VIRUS RESEARCH (2021)
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland
Ana da Silva Filipe et al.
NATURE MICROBIOLOGY (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
Helena Winstone et al.
JOURNAL OF VIROLOGY (2021)
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp et al.
NATURE (2021)
Clash of the titans: interferons and SARS-CoV-2
Nolwenn Jouvenet et al.
TRENDS IN IMMUNOLOGY (2021)
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity
Anwar Mohammad et al.
VIRUS RESEARCH (2021)
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
Suzannah J. Rihn et al.
PLOS BIOLOGY (2021)
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
Carl Graham et al.
IMMUNITY (2021)
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Thomas P. Peacock et al.
NATURE MICROBIOLOGY (2021)
Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation
Hsu-Yu Chen et al.
JOURNAL OF VIROLOGY (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
SARS-CoV-2 Variants in Patients with Immunosuppression
Lawrence Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
Enya Qing et al.
MBIO (2021)
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Caterina Prelli Bozzo et al.
NATURE COMMUNICATIONS (2021)
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng et al.
CELL REPORTS (2021)
Increased Transmissibility of the SARS-CoV-2 Alpha Variant in a Japanese Population
Hideo Tanaka et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
Tran Thi Nhu Thao et al.
NATURE (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Ruodan Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1
Pavitra Ramdas et al.
FRONTIERS IN MICROBIOLOGY (2020)
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins
Elisabeth Braun et al.
CELL REPORTS (2019)
Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses
Xuesen Zhao et al.
JOURNAL OF VIROLOGY (2018)
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
Carolina Petrillo et al.
CELL STEM CELL (2018)
More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins
Guoli Shi et al.
RETROVIROLOGY (2017)
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
Toshana L. Foster et al.
Cell Host & Microbe (2016)
Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion
Natalie K. Garcia et al.
VIRUSES-BASEL (2016)
Identification of an endocytic signal essential for the antiviral action of IFITM3
Rui Jia et al.
CELLULAR MICROBIOLOGY (2014)
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
Xuesen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
Kevin Tartour et al.
RETROVIROLOGY (2014)
Interferon-stimulated genes: roles in viral pathogenesis
John W. Schoggins
CURRENT OPINION IN VIROLOGY (2014)
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
Charles C. Bailey et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
Angharad E. Fenton-May et al.
RETROVIROLOGY (2013)
The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization
Rui Jia et al.
JOURNAL OF VIROLOGY (2012)
Cloning of the Repertoire of Individual Plasmodium falciparum var Genes Using Transformation Associated Recombination (TAR)
Annette Gaida et al.
PLOS ONE (2011)